LifeSigns

What LifeSigns does

LifeSigns (legal entity LS Devices Private Limited) is an AI-powered remote patient monitoring company headquartered in Chennai, India, with additional offices in Bangalore and Gurugram. Its core platform combines FDA-approved wearable biosensors capable of tracking up to eight vital signs (ECG, heart rate, SpO2, non-invasive blood pressure, pulse rate, respiration rate, skin temperature, posture and activity patterns, and urine output/flow trends) with a cloud-based software dashboard branded Nexus. The platform runs PreSense AI, a proprietary predictive model claimed to detect patient deterioration up to 26 hours in advance and to stratify patients into Code Blue, Stabilisation, Enhanced Care, and Standard Care categories. Supporting capabilities include a multilingual AI Clinician Assistant (Tamil, Malayalam, Hindi, Telugu), automated clinical documentation aligned to ICD, RxNorm, LOINC, and APACHE II standards, and real-time NEWS2/qSOFA scoring.

The company sells primarily to acute-care hospitals in India through a direct enterprise field sales motion, with named reference customers including Apollo Hospitals, Kauvery Hospital, Marengo CIMS, Manipal Hospital Whitefield, Cura Hospital, KIMS, Moolchand, Sri Ramakrishna, and Gem Hospital (85+ hospital partnerships cited). Revenue is generated via per-device rental subscriptions billed monthly, plus optional 24/7 Central Monitoring Team (CMT) managed-services and Hospital Support Executive (HSE) on-site training add-ons. Reported commercial traction includes 87,000-90,000 life-saving alerts generated and customer outcomes of approximately 90% reduction in Code Blue incidents and 78% decline in ICU readmissions. Regulatory positioning is anchored by US FDA approval (21 CFR Part 11), CDSCO Class B Clinical Decision Support System recognition, ISO 13485 certification, and HIPAA/GDPR compliance, with Epic EHR integration enabling workflow embedding in multi-hospital networks via hub-and-spoke monitoring.

In May 2026 LifeSigns closed its first institutional funding round from HealthQuad (HealthQuad Fund III) to support international expansion into Southeast Asia and GCC markets; the company had previously raised from Healthcare Capital in February 2025. Founded by Hari Subramaniam (CEO) and Dr. Girish Chandra (Director), with Shouri Akkineni also in the founding team, the company is moving from a domestic Indian footprint toward multi-country enterprise hospital commercialisation, extending its monitoring surface from inpatient wards into ambulances (Golden Hour use case) and home recovery via the Continuum Care module.

Name

LifeSigns

Legal name

LS Devices Private Limited

Website

https://lifesigns.us

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

51–100 employees

Short description

LifeSigns is an India-based, FDA-approved remote patient monitoring company that combines wearable biosensors with its PreSense AI predictive platform to detect patient deterioration up to 26 hours in advance and automate clinical documentation for hospitals, ambulances, and home care.

Ownership category

akta.pro rank

Product category

Remote Patient Monitoring

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)

akta.pro secondary industries

Hospital-at-Home & Acute-at-Home Remote Monitoring (step-down, escalation workflows) (HLALAFAH), Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)

Keywords

• Remote patient monitoring
• AI clinical intelligence
• Wearable biosensors
• Predictive patient deterioration
• Hospital monitoring platform

Headquarters

HQ city

Chennai

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Device Rental: Hardware and software provided on rental basis per device. Service fees calculated per Device provided for availing services, billed monthly. Devices remain property of Lifesigns.
2. Central Monitoring Team (CMT) Services: 24/7 remote patient monitoring by Lifesigns' central monitoring team with real-time alerts based on customer-defined thresholds. Included for initial 4-week deployment period, extended services available separately.
3. Software Dashboard Access: Cloud-based software and dashboard access through hosted services for monitoring, alerts, and clinical decision support.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Core offering

LifeSigns provides an FDA-approved AI-powered remote patient monitoring platform that pairs wearable biosensors (tracking up to eight vital signs including ECG, heart rate, SpO2, non-invasive blood pressure, pulse rate, respiration rate, skin temperature, and posture/activity patterns) with the Nexus cloud software and PreSense AI engine. The platform delivers continuous monitoring and predictive deterioration alerts across ambulance, ER, ICU, ward, and home care settings for acute care hospitals and emergency medical services in India.

Product overview

LifeSigns offers a unified AI-powered patient monitoring ecosystem combining FDA-approved wearable hardware with cloud software and predictive intelligence. The core platform, Lifesigns, integrates with the Nexus dashboard—a unified monitoring platform that stratifies patients by risk, provides AI clinical assistance, and automates documentation. Supporting modules include CMT (Central Monitoring Team) for outsourced 24/7 monitoring services and HSE (Hospital Support Executives) for on-site training and adoption support. The Continuum Care module extends monitoring to home recovery settings. The system monitors up to eight vital signs (ECG, SpO2, NIBP, pulse rate, respiration rate, temperature, posture, urine output) and delivers alerts with reported reductions of nearly 90% in code blue incidents and 78% in ICU readmissions.

Differentiator

Problem solved

Functional benefit

Brands

• Nexus: A unified continuous monitoring platform that brings every patient, from wards to transport to home recovery, into one precise, real-time view augmented with predictive intelligence. Features AI Clinician Assistant, smart documentation, and EHR-ready reports.

Products and services

• Lifesigns Platform Core AI-powered remote patient monitoring platform combining FDA-approved wearable devices with cloud software and predictive AI for continuous monitoring and proactive alerts across hospital, ambulance, and home care settings. Targeted at acute care hospitals seeking real-time vital signs tracking, AI-powered deterioration detection, and unified cross-department visibility.
• Lifesigns Nexus Unified continuous monitoring platform that aggregates patient data from ambulance, ER, ICU, ward, and home recovery into a single real-time view, augmented by PreSense AI predictive intelligence, a multilingual AI clinician assistant, automated documentation, secure video escalation, and Epic EHR integration. Targeted at hospitals and multi-hospital networks seeking a unified monitoring layer across departments.
• Continuum Care Remote patient monitoring solution launched in April 2023 that uses wearable biosensors tracking up to eight vital signs to extend monitoring beyond hospital discharge into home recovery settings. Targeted at home healthcare providers and hospital discharge programs.
• Central Monitoring Team (CMT) Service Managed 24/7 remote patient monitoring service staffed by LifeSigns' Central Monitoring Team, providing real-time alert triage based on customer-defined thresholds. Included for an initial 4-week deployment period with options to extend as a separate subscription. Targeted at hospitals that lack internal round-the-clock monitoring capacity.
• Hospital Support Executives (HSE) Service On-site implementation and training service where dedicated Hospital Support Executives help clinical staff master the LifeSigns monitoring systems for optimal adoption during the deployment phase. Targeted at hospital customers during initial rollout and ongoing optimization.

Quantifiable outcome

• Detection up to 26 hours in advance of patient deterioration
• +6 more outcomes

Named customers10 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature8 records

Partnerships

Three partnerships are on record, tiered flagship and core.

• Cura HospitalflagshipStrategic or Co-development Partner · 2 May 2025Cura Hospital in South Bangalore partnered with LifeSigns to enable round-the-clock real-time tracking of vital signs across hospital, home, and in-transit care settings. Collaboration focuses on cardiac care during the critical 'golden hour' after cardiac events, using wearable IoT devices and intelligent alerts to enable rapid intervention. Partnership also aims to bridge urban-rural healthcare divide by extending advanced monitoring to semi-urban and rural communities.
• EpiccoreTechnology or IntegrationEpic integration enables EHR-ready reports and compatibility with Epic electronic health record systems for seamless clinical workflow integration.
• PreSense (University of Michigan Health System, Microsoft, Oracle, FDA, GE)coreTechnology or IntegrationPreSense AI is built by a team with deep research and product experience across University of Michigan Health System, Microsoft, Oracle, the FDA, and GE. The AI helps clinicians predict risk, simplify documentation, and support real-time decisions.

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Masimo: Specialist in pulse oximetry, capnography, and continuous vital signs monitoring with FDA-cleared wearables (e.g., Radius PPG). Direct technology overlap with LifeSigns' wearable SpO2/ECG sensor stack.
• Philips (Patient Monitoring): Global incumbent offering ICU/ward patient monitors, telemetry, and RPM solutions. Overlaps with LifeSigns in continuous vitals monitoring and remote dashboard use cases.
• Medtronic: Diversified medtech with patient monitoring, LINQ insertable cardiac monitors, and Care Management Services (including RPM acquisitions). Adjacent competitor in cardiac monitoring.
• GE HealthCare: Global incumbent in patient monitoring (bedside monitors, central stations, ICU). Competes for Indian hospital budgets via its broad portfolio rather than LifeSigns' wearable-only niche.
• Mindray: Chinese-headquartered patient monitoring and IVD vendor with strong emerging-market hospital footprint (including India). Competes on price-sensitive bedside monitor and central station deals.

Direct peers

• Dozee: India-based AI-powered contactless RPM platform offering continuous vitals monitoring with wearable sensor mats for hospital wards and home settings. Direct competitor to LifeSigns in Indian hospital and home-care RPM.
• Current Health (Best Buy Health): RPM platform combining wearable vital signs monitoring with AI risk stratification and clinical dashboards. Now part of Best Buy Health; comparable platform approach to LifeSigns' Nexus.
• Stasis Labs: India-based connected care and RPM platform for ICUs, wards, and step-down units. Competes head-to-head with LifeSigns for Indian hospital monitoring deployments.
• Biofourmis: AI-driven RPM and virtual care platform focused on hospital-at-home and post-acute care with predictive analytics. Comparable to LifeSigns' AI-augmented RPM and continuum-care positioning.
• Huma (formerly Medopad): UK-based digital health platform offering RPM, AI risk prediction, and hospital-at-home modules. Comparable technology stack and predictive analytics to LifeSigns' PreSense AI.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/lifesignsindia
• YouTubeyoutube.com/@lifesignsindia
• Facebookfacebook.com/Lifesignsindia
• LinkedInlinkedin.com/company/lifesignsindia
• Instagraminstagram.com/lifesigns.india

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LifeSigns